SRC-3 deficiency protects host from Listeria monocytogenes infection through increasing ROS production and decreasing lymphocyte apoptosis

Xiaochun Xia,Yuan Chen,Jianming Xu,Chundong Yu,Wenbo Chen
DOI: https://doi.org/10.1016/j.intimp.2021.107625
IF: 5.714
2021-07-01
International Immunopharmacology
Abstract:<p><em>Listeria monocytogenes</em> is the third major cause of death among food poisoning. Our previous studies have demonstrated that steroid receptor coactivator 3 (SRC-3) plays a critical protective role in host defense against extracellular bacterial pathogens such as <em>Escherichia coli</em> and <em>Citrobacter rodentium</em>. However, its role involved in intracellular bacterial pathogen infection remains unclear. Herein, we found that SRC-3<sup>−/−</sup> mice are more resistant to <em>L. monocytogenes</em> infection after tail intravenous injection with <em>L. monocytogenes</em> compared with wild-type mice. After infecting with <em>L. monocytogenes</em>, SRC-3<sup>−/−</sup> mice exhibited decreased mortality rate, decreased bacterial load, less body weight loss, less proinflammatory cytokines and less severe tissue damage compared with wild-type mice. SRC-3<sup>−/−</sup> mice produced more ROS and decreased <em>L. monocytogenes</em>-induced lymphocyte apoptosis. Mechanically, SRC-3<sup>−/−</sup> mice displayed decreased expressions of negative regulator of ROS (NRROS) and interferon (IFN)-β and its target genes such as Daxx, Mx1 and TRAIL associated with apoptosis. Taken together, SRC-3 deficiency can protect host from <em>L. monocytogenes</em> infection through increasing ROS production and decreasing lymphocyte apoptosis via affecting the expressions of NRROS and IFN-β.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?